CIK 0001764013 · Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832771572
- Phone
- 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- 4 Open-market sale Chief Medical Officer sold 2,385 shares at $18.15 ($43,288)
- 4 Open-market sale Chief Medical Officer sold 1,160 shares at $17.24 ($19,998)
- 4 Open-market sale Chief Technology Officer sold 1,519 shares at $17.24 ($26,188)
- 4 Grant or award Chief Financial Officer acquired 208,388 shares (grant or award)
- 4 Grant or award Director acquired 25,016 shares (grant or award)
- 4 Grant or award Director acquired 25,016 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Technology Officer sold 1,925 shares at $14.79 ($28,471)
- 4 Open-market sale Chief Medical Officer sold 2,349 shares at $14.79 ($34,742)
- 4 Open-market sale Chief Financial Officer sold 2,993 shares at $14.89 ($44,566)
- 4 Open-market sale Chief Executive Officer sold 8,321 shares at $14.89 ($123,900)
- 4 Open-market sale Chief Technology Officer sold 5,004 shares at $12.99 ($65,002)
- 4 Open-market sale Chief Medical Officer sold 6,169 shares at $12.99 ($80,135)
- 4 Open-market sale Chief Financial Officer sold 11,063 shares at $12.99 ($143,708)
- 4 Open-market sale Chief Executive Officer sold 28,094 shares at $12.99 ($364,941)
- 4 Grant or award Chief Legal Officer acquired 50,787 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 76,181 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 76,181 shares (grant or award)
Page 4 of 18 · 360 filings